San Diego, CA · Founded 2018 · Privately Held (backing)
Developer of biotechnology drugs designed to reduce flare and tophi in gout patients. Arthrosi Therapeutics is based in San Diego, CA and was founded in 2018. It was valued at $1.5 billion at a merger or acquisition in Dec 2025, the last priced event on record. It has raised $299 million across 7 recorded rounds; the latest was a $60.9 million later-stage round in Jun 2025.
PMV mark · valuation
$1.5B
Oct 2026
Priced at
a merger or acquisition
Dec 2025
Total raised
$298.8M
Last round
Later Stage VC
Jun 2025
Cap table — not yet on record
Arthrosi Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Arthrosi Therapeutics with a free account
·The complete investor list: 16 names
·Watch Arthrosi Therapeutics: the Monday email on marks, rounds and moves
Where does Arthrosi Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Arthrosi Therapeutics's 7 recorded funding rounds.
